Cannabis & Autism
$49.00
Patricia Frye, MD details how both core and coexisting conditions associated with Autistic Spectrum Disorder (ASD) may improve with cannabis medicine. The course also addresses the limitations of pharmaceuticals that are currently FDA approved for autism as well as those that are commonly used but based on anecdotal evidence. Dr. Frye reviews approaches to chemovar profiles, dosing regimens and special considerations when treating ASD in children and young adults.
*Includes a certificate of completion
Category: Continuing Education
BECOME A MEMBER
Connect with healthcare professionals around the globe to get the most up-to-date medical cannabis information.
Get Involved
TAKE OUR COURSES
The curriculum brings hands-on practical guidance on how to develop personalized treatment regimens and more.